Advertisement

Index by author

July 01, 1992; Volume 42,Issue 1

A

  1. Abramson, R

    1. Expression of c-fos in human and murine multidrug-resistant cells.
      A Bhushan, R Abramson, J F Chiu and T R Tritton
      Molecular Pharmacology July 1992, 42 (1) 69-74;

  2. Adam, M

    1. Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;

  3. Asano, Y

    1. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

B

  1. Barber, R

    1. Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;

  2. Barsh, G

    1. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;

  3. Bell, G I

    1. Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;

  4. Bhushan, A

    1. Expression of c-fos in human and murine multidrug-resistant cells.
      A Bhushan, R Abramson, J F Chiu and T R Tritton
      Molecular Pharmacology July 1992, 42 (1) 69-74;

  5. Billingsley, M L

    1. Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells.
      S M Toggas, J K Krady and M L Billingsley
      Molecular Pharmacology July 1992, 42 (1) 44-56;

  6. Blaxall, H S

    1. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

  7. Boteju, L W

    1. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
      H G Cheon, L W Boteju and P E Hanna
      Molecular Pharmacology July 1992, 42 (1) 82-93;

  8. Brach, M A

    1. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

  9. Butcher, R W

    1. Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;

  10. Butt, E

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  11. Bylund, D B

    1. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

C

  1. Calvo, S

    1. Axoplasmic transport of [3H]ouabain binding sites and catecholamine secretion from an adrenergic nerve trunk.
      S Calvo, C González-García and V Ceña
      Molecular Pharmacology July 1992, 42 (1) 141-146;

  2. Caron, M G

    1. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

  3. Ceña, V

    1. Axoplasmic transport of [3H]ouabain binding sites and catecholamine secretion from an adrenergic nerve trunk.
      S Calvo, C González-García and V Ceña
      Molecular Pharmacology July 1992, 42 (1) 141-146;

  4. Chakinala, M M

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  5. Charleson, S

    1. Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;

  6. Cheon, H G

    1. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
      H G Cheon, L W Boteju and P E Hanna
      Molecular Pharmacology July 1992, 42 (1) 82-93;

  7. Chiu, J F

    1. Expression of c-fos in human and murine multidrug-resistant cells.
      A Bhushan, R Abramson, J F Chiu and T R Tritton
      Molecular Pharmacology July 1992, 42 (1) 69-74;

  8. Chruscinski, A

    1. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;

  9. Clark, R B

    1. Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;

  10. Coppolino, M G

    1. Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;

  11. Corbin, J D

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  12. Costa, T

    1. Selective interaction of beta 2- and alpha 2-adrenergic receptors with stimulatory and inhibitory guanine nucleotide-binding proteins.
      Y Ogino, C M Fraser and T Costa
      Molecular Pharmacology July 1992, 42 (1) 6-9;

D

  1. Daunt, D

    1. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;

  2. De Vos, S

    1. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

  3. Dichter, M A

    1. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.
      K Williams, M A Dichter and P B Molinoff
      Molecular Pharmacology July 1992, 42 (1) 147-151;

E

  1. Evans, J F

    1. Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;

F

  1. Francis, S H

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  2. Fraser, C M

    1. Selective interaction of beta 2- and alpha 2-adrenergic receptors with stimulatory and inhibitory guanine nucleotide-binding proteins.
      Y Ogino, C M Fraser and T Costa
      Molecular Pharmacology July 1992, 42 (1) 6-9;

G

  1. Goka, T J

    1. Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;

  2. González-García, C

    1. Axoplasmic transport of [3H]ouabain binding sites and catecholamine secretion from an adrenergic nerve trunk.
      S Calvo, C González-García and V Ceña
      Molecular Pharmacology July 1992, 42 (1) 141-146;

  3. Gruss, H J

    1. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

H

  1. Hanna, P E

    1. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
      H G Cheon, L W Boteju and P E Hanna
      Molecular Pharmacology July 1992, 42 (1) 82-93;

  2. Hatchett, R J

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  3. Herrmann, F

    1. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

I

  1. Iversen, L J

    1. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

J

  1. Jacobson, K A

    1. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
      K A Jacobson, G L Stiles and X D Ji
      Molecular Pharmacology July 1992, 42 (1) 123-133;

  2. Jani, J P

    1. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;

  3. Jastorff, B

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  4. Ji, X D

    1. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
      K A Jacobson, G L Stiles and X D Ji
      Molecular Pharmacology July 1992, 42 (1) 123-133;

K

  1. Kamboj, R K

    1. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

  2. Kim, S G

    1. Gender-related expression of rat microsomal epoxide hydrolase during maturation: post-transcriptional regulation.
      S G Kim and Y H Kim
      Molecular Pharmacology July 1992, 42 (1) 75-81;

  3. Kim, Y H

    1. Gender-related expression of rat microsomal epoxide hydrolase during maturation: post-transcriptional regulation.
      S G Kim and Y H Kim
      Molecular Pharmacology July 1992, 42 (1) 75-81;

  4. Kobilka, B

    1. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;

  5. Korczak, B

    1. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

  6. Krady, J K

    1. Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells.
      S M Toggas, J K Krady and M L Billingsley
      Molecular Pharmacology July 1992, 42 (1) 44-56;

L

  1. Law, S F

    1. Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;

  2. Lazarovici, P

    1. Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;

  3. Lazo, J S

    1. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;

  4. Lefkowitz, R J

    1. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

  5. Lester, D

    1. Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;

  6. Link, R

    1. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;

  7. Lomasney, J W

    1. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

M

  1. MacDonald, R L

    1. Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-D-aspartate receptor single-channel conductance.
      D M Rock and R L MacDonald
      Molecular Pharmacology July 1992, 42 (1) 157-164;

  2. Mancini, J A

    1. Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;

  3. Matsuda, Y

    1. Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;

  4. Mignano, J E

    1. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;

  5. Miledi, R

    1. Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology July 1992, 42 (1) 165-173;

  6. Mistry, J S

    1. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;

  7. Molinoff, P B

    1. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.
      K Williams, M A Dichter and P B Molinoff
      Molecular Pharmacology July 1992, 42 (1) 147-151;

  8. Morris, G

    1. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;

N

  1. Nishizaki, T

    1. Tunicamycin increases desensitization of junctional and extrajunctional acetylcholine receptors expressed in Xenopus oocytes by a mechanism independent of N-glycosylation blocking.
      T Nishizaki and K Sumikawa
      Molecular Pharmacology July 1992, 42 (1) 152-156;

  2. Nutt, S

    1. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

O

  1. Ogino, Y

    1. Selective interaction of beta 2- and alpha 2-adrenergic receptors with stimulatory and inhibitory guanine nucleotide-binding proteins.
      Y Ogino, C M Fraser and T Costa
      Molecular Pharmacology July 1992, 42 (1) 6-9;

  2. Olianas, M C

    1. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
      M C Olianas and P Onali
      Molecular Pharmacology July 1992, 42 (1) 109-115;

  3. Onali, P

    1. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
      M C Olianas and P Onali
      Molecular Pharmacology July 1992, 42 (1) 109-115;

P

  1. Polenzani, L

    1. Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology July 1992, 42 (1) 165-173;

  2. Proll, M A

    1. Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;

R

  1. Rahamim, E

    1. Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;

  2. Rasouly, D

    1. Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;

  3. Reisine, T

    1. Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;

  4. Rens-Domiano, S

    1. Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;

  5. Riedel, D

    1. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

  6. Rock, D M

    1. Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-D-aspartate receptor single-channel conductance.
      D M Rock and R L MacDonald
      Molecular Pharmacology July 1992, 42 (1) 157-164;

S

  1. Sandig, P

    1. Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;

  2. Schmitz, W

    1. Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;

  3. Schoepp, D D

    1. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

  4. Scholz, H

    1. Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;

  5. Scholz, J

    1. Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;

  6. Schulte Am Esch, J

    1. Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;

  7. Sebti, S M

    1. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;

  8. Seino, S

    1. Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;

  9. Sekhar, K R

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  10. Shabb, J B

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  11. Shekter, L

    1. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

  12. Stiles, G L

    1. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
      K A Jacobson, G L Stiles and X D Ji
      Molecular Pharmacology July 1992, 42 (1) 123-133;

  13. Sumikawa, K

    1. Tunicamycin increases desensitization of junctional and extrajunctional acetylcholine receptors expressed in Xenopus oocytes by a mechanism independent of N-glycosylation blocking.
      T Nishizaki and K Sumikawa
      Molecular Pharmacology July 1992, 42 (1) 152-156;

T

  1. Toggas, S M

    1. Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells.
      S M Toggas, J K Krady and M L Billingsley
      Molecular Pharmacology July 1992, 42 (1) 44-56;

  2. Tritton, T R

    1. Expression of c-fos in human and murine multidrug-resistant cells.
      A Bhushan, R Abramson, J F Chiu and T R Tritton
      Molecular Pharmacology July 1992, 42 (1) 69-74;

  3. Troll, U

    1. Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;

  4. True, R A

    1. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

V

  1. Vickers, P J

    1. Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;

W

  1. Wells, J N

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  2. Williams, K

    1. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.
      K Williams, M A Dichter and P B Molinoff
      Molecular Pharmacology July 1992, 42 (1) 147-151;

  3. Wolfe, L

    1. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;

  4. Woodward, R M

    1. Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology July 1992, 42 (1) 165-173;

  5. Wosnick, M A

    1. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

Y

  1. Yamada, Y

    1. Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;

Z

  1. Zimmerman, D M

    1. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;
Back to top

In this issue

Advertisement